Literature DB >> 27133294

Protrusion-localized STAT3 mRNA promotes metastasis of highly metastatic hepatocellular carcinoma cells in vitro.

Yan-Hong Liu1,2,3, Jia-Lu Jin4, Yu-Zhe Wang3, Ying Tan2, Ying-Ying Zhou3, Ting Peng3, Feng Li3, Wan-Dong Liang3, Pascal Chartrand5, Yu-Yang Jiang1,2,6, Zhi-Fa Shen7,3.   

Abstract

AIM: Recent evidence shows that localization of mRNAs and their protein products at cellular protrusions plays a decisive function in the metastasis of cancer cells. The aim of this study was to identify the variety of proteins encoded by protrusion-localized mRNAs and their roles in the metastasis and invasion of liver cancer cells.
METHODS: Highly metastatic hepatocellular carcinoma cell line HCCLM3 and non-metastatic hepatocellular carcinoma cell line SMMC-7721 were examined. Cell protrusions (Ps) were separated from cell bodies (CB) using a Boyden chamber assay; total mRNA population in CB and Ps fractions was analyzed using high-throughput direct RNA sequencing. The localization of STAT3 mRNA and protein at Ps was confirmed using RT-qPCR, RNA FISH, and immunofluorescence assays. Cell migration capacity and invasiveness of HCCLM3 cells were evaluated using MTT, wound healing migration and in vitro invasion assays. The interaction between Stat3 and growth factor receptors was explored with co-immunoprecipitation assays.
RESULTS: In HCCLM3 cells, 793 mRNAs were identified as being localized in the Ps fraction according to a cut-off value (Ps/CB ratio) >1.6. The Ps-localized mRNAs could be divided into 4 functional groups, and were all closely related to the invasive and metastatic properties. STAT3 mRNA accumulated in the Ps of HCCLM3 cells compared with non-metastatic SMMC-7721 cells. Treatment of HCCLM3 cells with siRNAs against STAT3 mRNA drastically decreased the cell migration and invasion. Moreover, Ps-localized Stat3 was found to interact with pseudopod-enriched platelet-derived growth factor receptor tyrosine kinase (PDGFRTK) in a growth factor-dependent manner.
CONCLUSION: This study reveals STAT3 mRNA localization at the Ps of metastatic hepatocellular carcinoma HCCLM3 cells by combining application of genome-wide and gene specific description and functional analysis.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27133294      PMCID: PMC4954761          DOI: 10.1038/aps.2015.166

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  30 in total

1.  Profiling signaling polarity in chemotactic cells.

Authors:  Yingchun Wang; Shi-Jian Ding; Wei Wang; Jon M Jacobs; Wei-Jun Qian; Ronald J Moore; Feng Yang; David G Camp; Richard D Smith; Richard L Klemke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

2.  STAT3 activation mediates epithelial-to-mesenchymal transition in human hepatocellular carcinoma cells.

Authors:  Chuan-hai Zhang; Feng-Lin Guo; Ge-Liang Xu; Wei-Dong Jia; Yong-Sheng Ge
Journal:  Hepatogastroenterology       Date:  2014-06

3.  Localized Rho GTPase activation regulates RNA dynamics and compartmentalization in tumor cell protrusions.

Authors:  Heather C Stuart; Zongjian Jia; Anat Messenberg; Bharat Joshi; T Michael Underhill; Hakima Moukhles; Ivan R Nabi
Journal:  J Biol Chem       Date:  2008-10-09       Impact factor: 5.157

4.  Mapping and quantifying mammalian transcriptomes by RNA-Seq.

Authors:  Ali Mortazavi; Brian A Williams; Kenneth McCue; Lorian Schaeffer; Barbara Wold
Journal:  Nat Methods       Date:  2008-05-30       Impact factor: 28.547

5.  Platelet-derived growth factor induces phosphorylation of multiple JAK family kinases and STAT proteins.

Authors:  M L Vignais; H B Sadowski; D Watling; N C Rogers; M Gilman
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

Review 6.  Control of cell migration through mRNA localization and local translation.

Authors:  Guoning Liao; Lisa Mingle; Livingston Van De Water; Gang Liu
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-09-28       Impact factor: 9.957

7.  Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

Authors:  H B El-Serag; A C Mason; C Key
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

8.  Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.

Authors:  Y Li; Y Tang; L Ye; B Liu; K Liu; J Chen; Q Xue
Journal:  J Cancer Res Clin Oncol       Date:  2002-12-04       Impact factor: 4.553

Review 9.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

10.  Global Analysis of mRNA, Translation, and Protein Localization: Local Translation Is a Key Regulator of Cell Protrusions.

Authors:  Faraz K Mardakheh; Angela Paul; Sandra Kümper; Amine Sadok; Hugh Paterson; Afshan Mccarthy; Yinyin Yuan; Christopher J Marshall
Journal:  Dev Cell       Date:  2015-11-09       Impact factor: 12.270

View more
  3 in total

1.  Overexpression of CD147 is associated with poor prognosis, tumor cell migration and ERK signaling pathway activation in hepatocellular carcinoma.

Authors:  Wenjing Xiao; Shufen Zhao; Fangzhen Shen; Jun Liang; Jing Chen
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

2.  UBE2J2 promotes hepatocellular carcinoma cell epithelial-mesenchymal transition and invasion in vitro.

Authors:  Shaopeng Chen; Ying Tan; Haihua Deng; Zhifa Shen; Yanhong Liu; Pan Wu; Chunyan Tan; Yuyang Jiang
Journal:  Oncotarget       Date:  2017-05-03

3.  Deconvolution of subcellular protrusion heterogeneity and the underlying actin regulator dynamics from live cell imaging.

Authors:  Chuangqi Wang; Hee June Choi; Sung-Jin Kim; Aesha Desai; Namgyu Lee; Dohoon Kim; Yongho Bae; Kwonmoo Lee
Journal:  Nat Commun       Date:  2018-04-27       Impact factor: 14.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.